Yu M, Zhao S, Fan X, Lv Y, Xiang L, Li R. Sodium–glucose cotransporter-2 inhibitors and abnormal serum potassium: a real-world, pharmacovigilance study. J Cardiovasc Med (Hagerstown). 2024;25(8):613–622

CAS  PubMed  Google Scholar 

Zamani M, Alizadeh-Tabari S, Ajmera V, Singh S, Murad MH, Loomba R. Global prevalence of advanced liver fibrosis and cirrhosis in the general population: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2024. https://doi.org/10.1016/j.cgh.2024.08.020

Article  PubMed  Google Scholar 

Younossi ZM, Golabi P, Price JK, Owrangi S, Gundu-Rao N, Satchi R, et al. The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes. Clin Gastroenterol Hepatol. 2024;22(10):1999-2010.e8

Article  PubMed  Google Scholar 

Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, et al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):234

Article  PubMed  PubMed Central  Google Scholar 

Drucker DJ. Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity. Diabetes Care. 2024;47:187–1888

Article  Google Scholar 

Ghosh P, Fontanella RA, Scisciola L, Pesapane A, Taktaz F, Franzese M, et al. Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists. Theranostics. 2023;13(14):4872–4884

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jalleh RJ, Rayner CK, Hausken T, Jones KL, Camilleri M, Horowitz M. Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions. Lancet Gastroenterol Hepatol. 2024;9(10):957–964

Article  CAS  PubMed  Google Scholar 

Morissette A, Mulvihill EE. Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist-based therapies. Trends Endocrinol Metab. 2024. https://doi.org/10.1016/j.tem.2024.07.012

Article  PubMed  Google Scholar 

Pang J, Feng JN, Ling W, Jin T. The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs-therapeutic potential exploration in lung injury. Acta Pharm Sin B. 2022;12(11):4040–4055

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shao S, Zhang X, Xu Q, Pan R, Chen Y. Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities. Pharmacol Ther. 2022;239: 108270

Article  CAS  PubMed  Google Scholar 

Barb D, Portillo-Sanchez P, Cusi K. Pharmacological management of nonalcoholic fatty liver disease. Metabolism. 2016;65(8):1183–1195

Article  CAS  PubMed  Google Scholar 

Lee JM, Sharifi M, Oshman L, Griauzde DH, Chua KP. Dispensing of glucagon-like peptide-1 receptor agonists to adolescents and young adults, 2020–2023. JAMA. 2024;331(23):2041–2043

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists in the treatment of type 2 diabetes—state-of-the-art. Mol Metab. 2021;46: 101102

Article  CAS  PubMed  Google Scholar 

Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, et al. A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med. 2021;384(12):1113–1124

Article  CAS  PubMed  Google Scholar 

Arai T, Atsukawa M, Tsubota A, Oikawa T, Tada T, Matsuura K, et al. Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction-associated steatotic liver disease: a prospective, multicentre, observational study. Diabet Obes Metab. 2024. https://doi.org/10.1111/dom.15898

Article  Google Scholar 

Palchuk MB, London JW, Perez-Rey D, Drebert ZJ, Winer-Jones JP, Thompson CN, et al. A global federated real-world data and analytics platform for research. JAMIA Open. 2023;6(2):35

Article  Google Scholar 

Bea S, Ko HY, Bae JH, Cho YM, Chang Y, Ryu S, et al. Risk of hepatic events associated with use of sodium–glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease. Gut. 2024. https://doi.org/10.1136/gutjnl-2024-332687

Article  PubMed  Google Scholar 

Wang L, Berger NA, Kaelber DC, Xu R. Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes. Gastroenterology. 2024;167(4):689–703

Article  CAS  PubMed  Google Scholar 

Bandyopadhyay S, Das S, Samajdar SS, Joshi SR. Role of semaglutide in the treatment of nonalcoholic fatty liver disease or non-alcoholic steatohepatitis: a systematic review and meta-analysis. Diabetes Metab Syndr. 2023;17(10): 102849

Article  CAS  PubMed  Google Scholar 

Stretton B, Kovoor J, Bacchi S, Chang S, Ngoi B, Murray T, et al. Weight loss with subcutaneous semaglutide versus other glucagon-like peptide 1 receptor agonists in type 2 diabetes: a systematic review. Intern Med J. 2023;53(8):1311–1320

Article  CAS  PubMed  Google Scholar 

Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33

Article  PubMed  PubMed Central  Google Scholar 

Krishnan A, Schneider CV, Hadi Y, Mukherjee D, AlShehri B, Alqahtani SA. Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study. Diabetologia. 2024;67(3):483–493

Article  CAS  PubMed  Google Scholar 

Rashid Z, Woldesenbet S, Khalil M, Iyer S, Khan MMM, Altaf A, et al. Impact of GLP-1RA on the risk of adverse liver outcomes among patients with alcohol-associated liver disease and type 2 diabetes. Liver Int. 2024. https://doi.org/10.1111/liv.16132

Article  PubMed  Google Scholar 

Yang CT, Yao WY, Yang CY, Peng ZY, Ou HT, Kuo S. Lower risks of cirrhosis and hepatocellular carcinoma with GLP-1RAs in type 2 diabetes: a nationwide cohort study using target trial emulation framework. J Intern Med. 2024;295(3):357–368

Article  CAS  PubMed  Google Scholar